Medicine & Life Sciences
B-Cell Chronic Lymphocytic Leukemia
100%
Ataxia Telangiectasia
49%
Mutation
23%
Poly(ADP-ribose) Polymerase Inhibitors
22%
DNA Damage
22%
Heterografts
21%
Alchemix
21%
olaparib
13%
Ubiquitin-Specific Proteases
12%
Synthetic Lethal Mutations
12%
Neoplasms
12%
Toll-Like Receptor 9
11%
Recombinational DNA Repair
11%
Natural History
8%
Ubiquitin
8%
Cytogenetics
8%
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8%
Phenotype
8%
Leukemia
8%
Histones
7%
Natural Killer Cells
7%
Cell Death
7%
Lymphocytes
7%
In Vitro Techniques
7%
Reactive Oxygen Species
6%
Therapeutics
6%
Radiation Tolerance
6%
Survival
6%
Topoisomerase Inhibitors
6%
Cell Count
6%
Sequence Deletion
6%
Double-Stranded DNA Breaks
6%
T-Lymphocytes
6%
Chromosome Aberrations
6%
Cyclin-Dependent Kinase 2
6%
Proteins
5%
AZD6738
5%
Alkylating Agents
5%
Pediatrics
5%
Chemistry
Mutation
19%
Cell Death
18%
Olaparib
15%
Ibrutinib
15%
Haematological
12%
Poly(ADPribose)
11%
Proliferative
11%
Refractory
11%
Phosphotransferase Inhibitor
10%
Lethal
10%
Genotoxic
10%
Histone
9%
Reduction
7%
Antineoplastic Agent
7%
Resistance
7%
Protein
7%
Metabolic
6%
Dose
6%
Time
5%
Plasma
5%
Tyrosine
5%